Respiratory dysfunction three months after severe COVID‐19 is associated with gut microbiota alterations
Journal of Internal Medicine2022Vol. 291(6), pp. 801–812
Citations Over TimeTop 10% of 2022 papers
Beate Vestad, Thor Ueland, Tøri Vigeland Lerum, Tuva B. Dahl, Kristian Holm, Andreas Barratt‐Due, Trine Kåsine, Anne Ma Dyrhol‐Riise, Birgitte Stiksrud, Kristian Tonby, Hedda Hoel, Inge Christoffer Olsen, Kateřina Nezvalová‐Henriksen, Anders Tveita, Ravinea Manotheepan, Mette Haugli, Ragnhild Eiken, Åse Berg, Bente Halvorsen, Tove Lekva, Trine Ranheim, Annika E. Michelsen, Anders Benjamin Kildal, Asgeir Johannessen, Lars Thoresen, Hilde Skudal, Bård Reiakvam Kittang, Roy Bjørkholt Olsen, Carl Magnus Ystrøm, Nina Vibeche Skei, Raisa Hannula, Saad Aballi, Reidar Kvåle, Ole Henning Skjønsberg, Pål Aukrust, Johannes R. Hov, Marius Trøseid, the NOR‐Solidarity study group
Abstract
Respiratory dysfunction after COVID-19 is associated with altered gut microbiota and persistently elevated LBP levels. Our results should be regarded as hypothesis generating, pointing to a potential gut-lung axis that should be further investigated in relation to long-term pulmonary dysfunction and long COVID.
Related Papers
- → Pulmonary Function in Pulmonary Sarcoidosis(2023)11 cited
- Comparison of high-resolution computed tomography with pulmonary function testing in symptomatic smokers.(2003)
- → Diffusion capacity for carbon monoxide in patients recovered from COVID-19: A useful parameter to assess pulmonary function(2022)2 cited
- → Pulmonary function involvement in scleroderma(2013)
- Inquiry on Pulmonary Diffusion Function Indices of DLco and Kco as Applied in Diagnosing Pulmonary Diseases(1995)